Piscidin-3 vs Clavanin A
Head-to-head comparison of Piscidin-3 (Piscidin-3 (hybrid striped bass antimicrobial peptide)) and Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
Piscidin-3
4.5
Clavanin A
4.4
| Property | Piscidin-3 | Clavanin A |
|---|---|---|
| Category | Marine-Derived | Marine-Derived |
| Full Name | Piscidin-3 (hybrid striped bass antimicrobial peptide) | Clavanin A (tunicate-derived antimicrobial peptide) |
| Molecular Weight | ~2.4 kDa | ~2.6 kDa |
| Half-Life | NR | NR |
| Amino Acids | 22 | 23 |
| Typical Dose | NR | NR |
| Route | in vitro|topical preclinical | in vitro|topical preclinical |
| Purity | ≥98% | ≥98% |
| Studies Count | 84 | 83 |
| Research Status | Pre-clinical | Pre-clinical |
Piscidin-3 Benefits
- ✓antibacterial
- ✓anti-biofilm
- ✓host-defense modulation
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
Piscidin-3 Dosing
NR|NR
Clavanin A Dosing
NR|NR
Piscidin-3 Side Effects
- ⚠hemolysis at high concentrations
- ⚠cytotoxicity risk
- ⚠protease sensitivity
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
Research Overview
Piscidin-3
Preclinical research indicates strong activity against bacterial membranes and drug-resistant strains. Analogs are being evaluated to balance potency with lower toxicity and better stability.
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.
Related Comparisons
Common Stacking Partners
Piscidin-3 stacks with:
Piscidin
Clavanin A stacks with:
Clavanin
marine-derivedantimicrobial peptidebioactive peptide